MedTrace Logo

IL-33, Endocan and Endothelial Cells

NCT03984383 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2022-11-04

No results posted yet for this study

Summary

The study aims to investigate the inflammatory response of endothelial cells to various stimulations, in particular the production of IL33 and of endocan in response to allergens, agonists of microorganisms and pollutants.

For that purpose, this project attempts to set up a biological collection of lung and umbilical cord endothelial cells.

Lung endothelial cells are resected from a surgical specimen, resulting from a lung cancer surgery.

Umbilical cord-derived endothelial cells are taken from the umbilical cord collected during the delivery.

Conditions

  • Endothelial Cell

Sponsors & Collaborators

  • University Hospital, Lille

    lead OTHER

Principal Investigators

  • Cécile Chenivesse · CHU Lille, Service de Pneumologie et Immuno-Allergologie

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-08
Primary Completion
2021-11-08
Completion
2021-11-08

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03984383 on ClinicalTrials.gov